Publication of the 2009 Annual Financial Report

BioAlliance Pharma SA (Euronext Paris: BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, announces today that its 2009 Annual Financial Report has been sent to the French Market Authorities and may be consulted at the http://www.onxeo.com website,
http://www.onxeo.com/investisseurs/informations-reglementees/
The Annual Financial Report comprises the report by the Chairman of the Supervisory Board on the Board’s activities and on internal controls, the statutory Auditors’ fees, and the annual information document.

100406EN_Annual Financial Report